In the trial, patients not eligible for aortic valve surgery will receive TAVR through transapical and transaortic approaches and will be compared with the results of patients in the original PARTNER A trial who received TAVR through the transapical approach.

FORBES: Two Medical Societies Break New Ground To Test Medical Device

While Ken Lerer, Huffington's original partner in the launch, was content to sell, Harman and Eric Hippeau, HuffPo's CEO and the fourth member of its small board of directors, held out, believing a billion-dollar public offering was possible given the patience to wait a year or two.

FORBES: Magazine Article

SMH's original German partner, dropped the project.

ECONOMIST: Not so Smart | The